Skip to main content
ARS Home » Plains Area » Grand Forks, North Dakota » Grand Forks Human Nutrition Research Center » Dietary Prevention of Obesity-related Disease Research » Research » Publications at this Location » Publication #279475

Title: Selenium and the regulation of cell cycle and apoptosis

item Zeng, Huawei

Submitted to: Book Chapter
Publication Type: Book / Chapter
Publication Acceptance Date: 5/19/2012
Publication Date: N/A
Citation: N/A

Interpretive Summary: Selenium is an essential trace element for humans and animals, and Se deficiency is associated with several disease conditions such as the immune impairment. In addition, selenium intakes that are greater than the recommended daily allowance (RDA) appear to protect against certain types of cancers. In humans and animals, cell proliferation and death must be regulated to maintain tissue homeostasis, and it has been well documented that the control of cell cycle progression and apoptosis is directly related to numerous human diseases. Thus, the elucidation of the mechanisms by which selenium regulates the cell cycle and apoptosis can lead to a better understanding of the nature of selenium’s essentiality and its role in disease prevention. This article reviews the status of knowledge concerning the effect of selenium on cell cycle and apoptosis. The information will be useful information for scientists and health-care professionals who are interested in nutrition and chronic-disease prevention.

Technical Abstract: Selenium was discovered by Berzelius in 1817, and the essentiality of Se was demonstrated that trace amounts of Se protected against liver necrosis in vitamin E deficient rats in the mid-1950s. The benefits of Se are many including protection against cancer, heart diseases, muscle disorders, immunity and age-related diseases. The health-promoting properties of Se are due to vital functions of selenoproteins, and Se compounds have been considered to act as Se donors for selenoprotein biosynthesis which is required for normal physiology. However, chemoprevention, in most cases, was obtained with small Se-metabolite molecules such as selenide and methylselenol through supranutritional intake. Investigations into the protective role of Se had been undertaken for many years both in animal and case-control, but not all nutritional intervention studies show that high Se intakes effectively reduce cancer risk. This is because there is a relatively narrow margin between Se intakes that result in deficiency or toxicity. Various underlying mechanisms have been presented which, however, may also differ depending on the chemical form of Se and the time point of intervention. The regulation of cell cycle and apoptosis is the most fundamental biological process related to Se’s health-promoting properties. It has been well recognized that Se plays a critical role in cell proliferation but the mechanism remains elusive. In humans and animals, cell proliferation must be regulated to maintain tissue homeostasis. The eukaryotic cell cycle is divided into four major phases as follows: the G1 phase before DNA replication, the periods of DNA synthesis (S phase), the G2 phase before cell division and cell division (M phase). The cell cycle is a conserved mechanism by which eukaryotic cells replicate themselves, and apoptosis is also a highly conserved mechanism by which eukaryotic cells commit suicide. Apoptosis, a programmed cell death, enables an organism to eliminate unwanted and defective cells during normal development, turnover and pathological conditions. There are several putative mechanisms by which Se modulates cell cycle and apoptosis, and these mechanistic aspects may reveal the relationship between Se and health outcomes, including cancer and inflammatory disorders.